DERM 08: Skin and Soft Tissue Infections (SSTIs) Flashcards
What are skin and soft tissue infections (SSTIs)?
- common infections
- incidence unknown
- increasing frequency – invasive infections, drug-resistant infections
What is the pathophysiology of SSTIs?
- skin and soft tissue infections may involve any or all layers of skin, fascia, and muscle
- may spread from initial site of infection → complications (sepsis, endocarditis)
What are the predisposing factors for SSTIs?
- high concentration of bacteria on skin (> 105 CFUs)
- excessive moisture
- inadequate blood supply
- availability of bacterial nutrients
- damage to skin layers allowing for bacterial penetration
What are the normal skin flora?
bacteria:
- gram-positive: coagulase-negative staphylococci, micrococci, corynebacterium species (diptheroids), propionibacterium species
- gram-negative: acinetobacter species
fungi:
- malassezia species
- candida species
What are the causative pathogens of SSTIs?
gram-positive bacteria – most common
- staph aureus
- coagulase-negative staphylococci (CoNS)
- diptheroids
- strep pyogenes (group A strep)
gram-negative bacteria – less common
- E. coli
- enterobacteriacae
- acinetobacter
What are the 4 classes of STIs and their management/treatment options?
class 1: afebrile, otherwise healthy
- management: outpatient, oral/topical antibiotics
class 2: febrile, ill-appearing, no unstable comorbidities
- management: outpatient or short hospitalization, oral or IV antibiotics
class 3: toxic appearance, ≥ 1 co-morbidity
- management: hospitalization, IV antibiotics
class 4: sepsis or life-threatening infection
- management: hospitalization, IV antibiotics +/- surgery
What are the goals of therapy for SSTIs?
- eradication of infection (if possible)
- prevention of complications
- prevent/minimize adverse drug reactions
What is impetigo?
- superficial skin infection
- common in children (age 2-5 years), and during hot/humid weather
- contagious – transmitted from person to person
- non-bullous and bullous forms
What are the risk factors for impetigo?
- warm, humid weather
- close contact environments (ie. daycare)
- anything that breaks integrity of skin – burns, cuts or scrapes, bug bites, eczema
What are the signs and symptoms of impetigo?
- red rash with vesicles
- vesicles rupture → ooze for few days → golden or honey-coloured crust
- mild pruritis (itchiness)
What is non-bullous impetigo?
- most common form
- papules → vesicles (w/ erythema) → pustules → thick crusts (golden appearance)
- evolution occurs over 1 week
- lesions < 1.5 cm in diameter
- usually face and extremities
- multiple lesions but localized
- mild tenderness, itchiness
What pathogen results in non-bullous impetigo?
staph aureus, strep pyogenes
What is bullous impetigo?
- primarily seen in young children
- papules → vesicles → flaccid bullae with clear yellow fluid → bullae with darker, pus fluid → rupture → thin brown crust
- lesions > 1.5 cm in diameter
- trunk usually affected, and groin, armpits, skin folds can be infected
- fewer lesions than non-bullous
What pathogen results in bullous impetigo?
staph aureus
- produces toxin A → exfoliation (causes loss of cell adhesion in epidermis)
What is ecthyma?
- ulcerative form of impetigo
- lesions epidermis → dermis
- ‘punched-out’ ulcers covered with yellow crust and purple borders
What pathogen results in ecthyma?
staph aureus (most common), strep pyogenes
What are the non-pharmacological measures for impetigo?
- crust removal – gentle washing (clean warm water, mild soap)
- saline compresses – apply for 10 minutes, 3-4x per day
How can the transmission of impetigo be prevented?
- wash hands
- cover draining lesions with clean, dry dressings
- avoid scratching lesions
- keep fingernails short
- avoid sharing towels
- wash patient’s clothes and linens separately from rest of laundry
What is the treatment for mild impetigo (children and adults)?
- limited number of lesions
- can use ‘wait and see’ approach
- minor ailments prescribing in BC
- antibiotics – shorten duration, speed healing
- mupirocin 2% ointment to lesions TID
- fusidic acid 2% cream to lesions TID – increase resistance
- duration: 5 days
- topical antibiotics as effective as oral antibiotics for mild impetigo
What is the treatment for moderate to severe impetigo (children)?
cephalexin 15-25 mg/kg/dose PO q6h (max 500 mg/dose)
- avoid cloxacillin due to taste, unless child can swallow capsules
if suspected MRSA or cephalexin/cloxacillin allergy:
- TMP/SMX 4 mg/kg/dose (TMP component) PO BID
- doxycycline 2 mg/kg/dose PO q12h
- clindamycin 13 mg/kg/dose PO TID – avoid due to taste unless child can swallow capsules
duration: 7 days
What is the treatment for moderate to severe impetigo (adults)?
- cephalexin 250 mg PO QID
- cloxacillin 250 mg PO QID
if suspected MRSA or cephalexin/cloxacillin allergy:
- clindamycin 450 mg PO TID
- TMP/SMX 1 DS tablet (160/800 mg) PO BID
- doxycycline 100 mg PO BID
duration: 7 days
When should impetigo be referred to a physician/NP?
- age < 1 year
- fever or chills
- malaise or fatigue
- immunocompromised
- recurrent episodes (ie. > 2 distinct episodes in past 6 months)
- history of valvular heart disease
- ‘extensive disease’ (moderate-severe) – > 2 affected areas (numerous lesions) or ‘widespread’ erythema
- bullous impetigo (even if considered mild)
What is the pathophysiology of cellulitis?
- initially affects epidermis and dermis
- may spread to superficial fascia
- serious disease – may spread through lymphatic system to blood
What are the signs and symptoms of cellulitis?
- fever, chills, malaise
- area feels hot and painful
- erythema and edema
- non-elevated and poorly marginated lesions
- warm to touch
- inflammation
- tender lymphadenopathy
- lab tests: blood cultures, wound cultures